InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (12 ops.)
Explore the full record of transactions filed by Martin Michael Robert, Directeur Commercial. Director active across 1 companies, notably Aurinia Pharmaceuticals Inc.. Aggregated, 23 reports have been recorded. Total volume traded: €3.9m. The latest transaction was filed on 2 March 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations23 total
08,500 shares0
Common Stock
SEC:0001628280-22-005130:0·
€1m50,000 shares@ €26.027751.0% of flow
Common Shares
SEC:0001628280-21-023169·
€1m50,000 shares@ €26.02770.062% mcap25.5% of flow
Common Shares
SEC:0001628280-21-023169:0·
€124,60345,000 shares@ €2.7694.9% of flow
Common Stock
SEC:0001628280-21-021477·
€124,60345,000 shares@ €2.7690.0059% mcap2.4% of flow
Common Stock
SEC:0001628280-21-021477:0·
€128,77028,500 shares@ €4.51835.0% of flow
Common Stock
SEC:0001628280-21-019048·
€128,77028,500 shares@ €4.51830.0061% mcap2.5% of flow
Common Stock
SEC:0001628280-21-019048:0·
€197,54444,000 shares@ €4.48967.7% of flow
Common Stock
SEC:0001628280-21-018782·
€197,54444,000 shares@ €4.48960.0094% mcap3.9% of flow
Common Stock
SEC:0001628280-21-018782:0·
€112,17425,000 shares@ €4.4874.4% of flow
Common Shares
SEC:0001628280-21-018603·
€112,17425,000 shares@ €4.4870.0053% mcap2.2% of flow
Common Shares
SEC:0001628280-21-018603:0·
€114,6197,500 shares@ €15.28264.5% of flow
Common Stock
SEC:0001628280-21-018219·
€114,6197,500 shares@ €15.28260.0054% mcap2.2% of flow
Common Stock
SEC:0001628280-21-018219:0·
€340,85722,500 shares@ €15.149213.3% of flow
Common Stock
SEC:0001628280-21-017720·
€340,85722,500 shares@ €15.14920.016% mcap6.7% of flow
Common Stock
SEC:0001628280-21-017720:0·
€68,1955,000 shares@ €13.63892.7% of flow
Common Stock
SEC:0001628280-21-016403·
€68,1955,000 shares@ €13.63890.0032% mcap1.3% of flow
Common Stock
SEC:0001628280-21-016403:0·
€58,5015,000 shares@ €11.70022.3% of flow
Common Stock
SEC:0001628280-21-014882·
€58,5015,000 shares@ €11.70020.0028% mcap1.1% of flow
Common Stock
SEC:0001628280-21-014882:0·
€57,6375,000 shares@ €11.52742.3% of flow
Common Stock
SEC:0001628280-21-012730·
€57,6375,000 shares@ €11.52740.0027% mcap1.1% of flow
Common Stock
SEC:0001628280-21-012730:0·
€49,73420,000 shares@ €2.48671.9% of flow
Common Stock
SEC:0001628280-21-010021·
€49,73420,000 shares@ €2.48670.0024% mcap1.0% of flow
Common Stock
SEC:0001628280-21-010021:0·
23 of 23 declarations
About Martin Michael Robert
Martin Michael Robert is an executive at Aurinia Pharmaceuticals Inc.
